Navigation Links
Amgen’s Second Quarter 2011 Revenue Increased 4 Percent to $4.0 Billion
Date:7/29/2011

ersion from NEUPOGEN to Neulasta.

Enbrel® (etanercept) sales increased 9 percent to $956 million in the second quarter of 2011 versus $877 million in the second quarter of 2010, driven primarily by increases in the average net sales price and unit demand.  This sales increase reflects segment growth, offset partially by share declines. ENBREL remains the leader in both the rheumatology and dermatology segments.

Sales of Sensipar® / Mimpara® (cinacalcet) increased 16 percent to $199 million in the second quarter of 2011 versus $172 million in the second quarter of 2010.  Sales of Vectibix® (panitumumab) increased 13 percent to $81 million in the second quarter of 2011 versus $72 million in the second quarter of 2010.  Sales of Nplate® (romiplostim) increased 36 percent to $75 million in the second quarter of 2011 versus $55 million in the second quarter of 2010. These increases were driven by increases in global demand.

Sales of Prolia® (denosumab) in the second quarter of 2011 were $44 million, reflecting continued adoption by physicians and expanded access from payers in the U.S. and internationally.

U.S. sales of XGEVA® (denosumab) were $73 million in the second full quarter following launch.  Sales were driven by increased segment share as well as overall segment growth.

Operating Expense Analysis on an Adjusted Basis:Cost of Sales decreased to 14.6 percent of product sales in the second quarter of 2011 versus 15.2 percent of product sales in the second quarter of 2010.  This decrease was driven primarily by lower bulk material cost, due to higher utilization, offset partially by the Puerto Rico excise tax.  Excluding the $45 million impact of the excise tax, cost of sales would have been 13.5 percent of product sales for the quarter.

Research and Development (R&D) expenses increased 26 percent to $808 million in the second quarter of 2011
'/>"/>

SOURCE Amgen
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19

Related medicine technology :

1. Amgen’s Third Quarter 2010 Revenue Unchanged at $3.8 Billion Versus Prior Year
2. Amgen’s Fourth Quarter 2010 Adjusted Earnings Per Share Increased 11 Percent to $1.17; Full Year 2010 Adjusted Earnings Per Share Increased 6 Percent to $5.21
3. Amgen’s First Quarter 2011 Revenue Increased 3 Percent to $3.7 Billion
4. Spherix Reports Second Quarter Earnings
5. Tapestry Reports Second Quarter 2007 Results
6. Callisto Reports on Second-Quarter 2007 Milestones
7. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
8. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
9. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
10. Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs
11. Genzyme Announces Second Pivotal Mozobil Trial Meets Primary Endpoint
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... -- Zimmer Holdings, Inc. (NYSE and SIX: ZMH), a global ... participating in the Morgan Stanley 2014 Global Healthcare Conference ... New York , on Tuesday, September 9, 2014.  ... will be presenting at 9:10 a.m. Eastern Time.  ... join Mr. Dvorak for the Q&A session. ...
(Date:8/27/2014)... -- Sinovac Biotech Ltd. (NASDAQ: SVA ), a leading ... announced the results of the Company,s 2014 Annual General Meeting of ... , PRC. The required quorum, a majority of the common ... shareholders approved the following proposals:  , The re-election of ... Anderson , Kenneth Lee and Meng Mei ...
(Date:8/27/2014)...  AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX ), ... commercialization of innovative therapies for the treatment of acute ... be participating at the FBR Healthcare One on One ... Conference.  Details of the two events are as follows: ... Wednesday September 3 rd Location: Four Seasons, ...
Breaking Medicine Technology:Sinovac Announces Results of 2014 Annual General Meeting of Shareholders 2AcelRx Pharmaceuticals to Participate in Two Upcoming Investor Events 2AcelRx Pharmaceuticals to Participate in Two Upcoming Investor Events 3
... April 18, 2011 Qmed.com, a UBM Canon ... informative video clips of products and services available ... Vault . Qmed is a free online search ... access to pre-qualified medical device suppliers. ...
... 18, 2011 Nektar Therapeutics (Nasdaq: NKTR ) ... March 31, 2011 on Wednesday, April 27, 2011, after the ... executive officer, will host a conference call to review the ... Time (PT). The press release and a ...
Cached Medicine Technology:Qmed Video Vault Showcases Innovative New Products and Services Available to Medical Device Manufacturers 2Nektar to Announce Financial Results for the First Quarter of 2011 on Wednesday, April 27, 2011, After Close of U.S.-Based Financial Markets 2
(Date:8/27/2014)... August 27, 2014 IQ Formulations ... today announced its continued support of the Cystic Fibrosis ... participated in a fundraising campaign led by TigerFitness.com in ... IQ Formulations’ sales were donated to the respected nonprofit ... a TigerFitness.com fundraiser to support Isla, a young girl ...
(Date:8/27/2014)... Aspirus Wausau Hospital today announced the first extensive ... O.R. at Aspirus Wausau Hospital, in Wausau, WI. ... will be Buzz, a centralized surgical hub for operating ... navigation, imaging and communications connectivity. , Buzz Digital ... hardware all controlled from the full HD 42” multi-touch ...
(Date:8/27/2014)... 27, 2014 SCOTT Sports is ... Utah’s first indoor mountain bike and BMX park. SCOTT ... bikes in both adult and youth sizes for the park’s ... a distribution warehouse in Ogden, Utah, recently moved its U.S. ... “We are proud to be a partner with the Wasatch ...
(Date:8/27/2014)... By Steven Reinberg ... -- A hormone used to reduce the need for blood ... new study suggests. Synthetic erythropoietin (EPO), which stimulates red ... shortly after preterm birth, said lead researcher Dr. Petra Huppi, ... of Geneva, in Switzerland. "The real test of whether ...
(Date:8/27/2014)... CIC microGUNE, the Co-operative Research Centre into ... seeks to generate innovative solutions based on ... mobility industry and life sciences, among others. ... Tecnun are collaborating with CIC microGUNE on ... funded by the Etortek 2013-2014 programme of ...
Breaking Medicine News(10 mins):Health News:IQ Formulations Contributes Sizeable Donation to Cystic Fibrosis Foundation 2Health News:Aspirus Wausau Hospital Announces First Large Scale Digital Operating Room Integration Project in the US 2Health News:Aspirus Wausau Hospital Announces First Large Scale Digital Operating Room Integration Project in the US 3Health News:SCOTT Sports to Sponsor Wasatch Indoor Bike Park 2Health News:Hormone Might Help Preemies' Brains 2Health News:Hormone Might Help Preemies' Brains 3Health News:Microtechnologies for driving forward mobility and human health 2
... hearing damage from acoustic shock, say health experts. // , ... functioning of the ear or of the nervous system, which ... earphone by a sudden sharp rise in the acoustic pressure ... a bleep or any unexpected noise. Two thirds of call ...
... For patients on hemodialysis, the use of dialysis filters ... approach to the common problem of anemia, reports a ... 39th Annual Meeting and Scientific Exposition in San Diego. ... Hospital in Vicenza, Italy, analyzed the outcomes of 172 ...
... acquired respiratory syndrome (SARS), has been responsible for around ... Researchers from Brookhaven’s biology department and the National Synchrotron ... controlling the virus . They have successfully identified a ... new anti-SARS virus drugs.The stage has been set now ...
... bypass surgery for morbid obesity have increased risk factors ... paper being presented at the American Society of Nephrology's ... ,'Gastric bypass surgery appears to lead to changes ... the formation of kidney stones,' comments Dr. Rajiv Kumar ...
... of clear information about the risks of nanotechnology in ... this powerful potential according //to 14 top international scientists ... issue of the journal Nature. The paper, 'Safe Handling ... nanotechnology risk that must be met if the technology ...
... China for stem cell treatment died on Thursday night in ... ,Willie Terpstra, a New Zealander, was diagnosed with motor ... months ago to have a foetal cell tansplantation operation in ... of voluntary muscle activity that aids speaking, breathing and swallowing. ...
Cached Medicine News:Health News:Vitamin E-Coated Dialysis Filters Help Fight Anemia in Hemodialysis Patients 2Health News:Scientists Close To Identifying Anti-viral Drug for SARS 2Health News:Scientists Close To Identifying Anti-viral Drug for SARS 3Health News:Gastric Bypass Surgery May Lead to Increased Kidney Stone Risk 2Health News:Fear of Possible Harm Hinder Nanotech Development 2
... 6 is an enzyme immunoassay (EIA) test ... various specific nuclear antigens (SS-A, SS-B, RNP/Sm, ... is used as an aid in the ... connective tissue disease (MCTD), Sjgren's syndrome and ...
The Invacare Pulse Oximeter provides fast, reliable SpO2 and pulse-rate measurements on any patient from infant to adult. It's designed for simple, accurate spot-checking and is a member of a full-li...
Rad-5v signal extraction pulse oximeter™...
... WristOx® 3100 is a small, ... be worn comfortably on the ... daily activities and for overnight ... the WristOx is intended to ...
Medicine Products: